Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the following investor conferences.
Experience an amazing investing opportunity at the William Blair 43rd Annual Growth Stock Conference in Chicago, IL! Engage in dynamic discussions with esteemed industry professionals and explore unique strategies to build your portfolio. Discover the newest trends and best practices in the investing world and hear from leaders in the field. Don’t miss out on this once-in-a-lifetime chance to gain invaluable insights into the world of investing.
On Monday, June 12th, Goldman Sachs is hosting its 44th Annual Global Healthcare Conference in Dana Point, CA. Join us for a unique Fireside Chat and hear insights from some of the leading minds in healthcare starting at 4:00 p.m. Pacific Time! Don’t miss this incredible opportunity to broaden your knowledge of the industry and get up-to-date information about the latest developments in healthcare.
About Guardant Health
Guardant Health is revolutionizing the fight against cancer! Its proprietary tests, vast data sets and innovative analytics platform are helping to drive progress in precision oncology treatments that improve patient outcomes and reduce healthcare costs throughout the cancer care continuum. Its commercial offerings include Guardant360®, Guardant360 CDx, Guardant360 TissueNext™, Guardant360 Response™, GuardantINFINITY™ and Guardant Reveal™ for advanced-stage and early-stage cancer respectively, as well as Shield™ test for populations eligible for cancer screening. Join Guardant Health on its mission to conquer cancer!